Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Neoadjuvant endocrine therapy for estrogen receptor positive breast cancer in an African setting
Background Several studies have reported response rates for ER positive cancers on neoadjuvant endocrine therapy (NET), with lower toxicity compared to neoadjuvant chemotherapy (NCT). During the first wave of the COVID pandemic, clinician preference for NET increased significantly, buying time for h...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of General Surgery
2023
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Neoadjuvant endocrine therapy for estrogen receptor positive breast cancer in an African setting
- The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer
- Crosstalk between the androgen and estrogen receptors in breast cancer
- Investigating progesterone and estrogen receptor crosstalk in breast cancer
- Investigating progestin-mediated crosstalk between the androgen receptor and estrogen receptor subtypes in breast cancer cell lines
- Combinatorial treatments of tamoxifen with SM6Met, a selective estrogen receptor subtype modulator (SERSM), from Cyclopia subternata are superior to current endocrine treatments in breast cancer cell models.
- Postoperative Complications Following Neoadjuvant Therapy Across Different Oncoplastic Breast Surgery Techniques: A Retrospective Comparative Study in Breast Cancer Patients